{"prompt": "['PREDM', 'Page 13', 'participants in the general population with prediabetes over the 16-course core', 'curriculum. 32', 'Frailty is typically described in older adults and identifies individuals who are at', 'risk for adverse health outcomes and early mortality. 33,34 However, Ness et al.', 'identified that the prevalence of frailty (7.9%) and prefrailty (22.2%), defined by', 'the Fried criteria, among survivors in the SJLIFE cohort at a mean age of 33', 'years was similar to the prevalence reported among adults over 65 years of', 'age. 33,34 Observational studies among older adults have demonstrated that', 'metformin reduces all-cause mortality and frailty-related diseases, including', 'reduced cancer and cardiovascular disease compared to both non-diabetes and', 'diabetics using non-metformin regimens. 35,36 These observations, as well', 'as', 'animal studies suggesting metformin has anti-aging effects, has led to research', 'interest and there is at least one ongoing study of frailty prevention in prediabetic', 'adults using metformin. 37', '3.0', 'PARTICIPANT ELIGIBILITY CRITERIA AND STUDY', 'ENROLLMENT', '3.1 Inclusion Criteria', 'We will recruit to enroll 41 survivors who are at least 18 but <45 years of age', 'who participate in the St. Jude Lifetime Cohort Study (SJLIFE) and have been', 'identified to have prediabetes defined as hemoglobin Alc (HbAlc) 5.7-6.4% or', 'fasting plasma glucose (FPG) 100-125 mg/dl.', '3.1.1 Participant in SJLIFE', '3.1.2 >18 and <45 years of age', '3.1.3 Prediabetic: fasting plasma glucose 100-125 mg/dL, hemoglobin Alc 5.7-', '6.4% (either or both criteria may be present)', 'According to institutional and NIH policy, the study will accession research', 'participants regardless of sex and ethnic background. Institutional', 'experience confirms broad representation in this regard.', '3.2 Exclusion Criteria', '3.2.1', 'Absence of treatment related diabetes risk. Survivors will be excluded if', 'their cancer treatment required observation only, surgery alone not', \"St. Jude Children's Research Hospital\", 'Initial version, dated: 04-10-20', 'IRB approkB date NUMBER: 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']['PREDM', 'Page 14', 'involving the abdomen or brain, radiation alone not involving the chest', '(pancreatic risk), abdomen or brain (e.g. retinoblastoma treated with', 'enucleation alone, melanoma of an extremity treated with excision alone,', 'neuroblastoma in an infant requiring observation only)', '3.2.2 Diabetes at baseline assessment: FPG >126 mg/dL, HbAlc >6.5% or', 'previous diagnosis by a physician (except gestational diabetes that resolved', 'post-partum)', '3.2.3 BMI <19 kg/m\u00b2', '3.2.4 Current metformin use (including for any period >30 days in the past 1yr)', '3.2.5 Known allergy to metformin', '3.2.6 Current use of other oral glucose lowering medications, non-insulin', 'injectable diabetes medications or insulin (Appendix)', '3.2.7 Current participation in a lifestyle change program', '3.2.8 Chronic kidney disease > stage IIIb (eGFR < 45 mL/min)', '3.2.9 Severe cardiovascular disease or recent intervention (NYHA class >2 or heart', 'failure hospitalization in the past 6mo, Aortic stenosis, Heart block', 'including LBBB or 3rd degree AV block, SBP >180 or DBP > >105 mmHg,', 'myocardial infarction or coronary revascularization in the past 1 month)', '3.2.10 Severe hepatic dysfunction: cirrhosis or AST/ALT >3 times upper limit of', 'normal', '3.2.11 Pulmonary disease with dependence on oxygen or daily use of', 'bronchodilators', '3.2.12 Weight loss > -10% in the past 6 months', '3.2.13 Bariatric surgery in the past 2 years', '3.2.14 Pregnant, within 3 months post-partum, nursing, or planning to become', 'pregnant', '3.2.15 Anemia: hematocrit <36% in males or <33% in females', '3.2.16 Ongoing alcohol or substance abuse using criteria from the AUDIT and', 'DAST questionnaires (Appendix)', '3.2.17 Diagnosis of schizophrenia or other psychotic disorder', \"St. Jude Children's Research Hospital\", 'Initial version, dated: 04-10-20', 'IRB approkB date NUMBER: 00-00-00 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']\n\n###\n\n", "completion": "END"}